Treace Medical Concepts Schedules 2024 Annual Meeting of Stockholders

TL;DR

<b>Treace Medical Concepts will hold its 2024 virtual Annual Meeting of Stockholders on May 21, 2024, to vote on director elections, executive compensation, and auditor ratification.</b>

AI Summary

TREACE MEDICAL CONCEPTS, INC. (TMCI) filed a Proxy Statement (DEF 14A) with the SEC on April 2, 2024. The 2024 Annual Meeting of Stockholders for Treace Medical Concepts, Inc. will be held virtually on May 21, 2024, at 11:00 a.m. Eastern Time. Stockholders will vote on the election of three Class III directors for a three-year term. An advisory vote on the compensation of named executive officers is scheduled. An advisory vote on the frequency of future executive compensation votes will occur. Grant Thornton LLP is proposed for ratification as the independent registered public accounting firm for fiscal year 2024.

Why It Matters

For investors and stakeholders tracking TREACE MEDICAL CONCEPTS, INC., this filing contains several important signals. The meeting's virtual format allows for broader participation and accessibility for stockholders globally. Key governance matters, including director elections and executive compensation, will be decided, impacting the company's strategic direction and accountability.

Risk Assessment

Risk Level: — TREACE MEDICAL CONCEPTS, INC. shows moderate risk based on this filing. The filing is a routine proxy statement (DEF 14A) announcing the annual meeting and agenda items, with no new financial or operational disclosures that would indicate immediate risk.

Analyst Insight

Stockholders should review the proxy materials to make informed voting decisions on director nominees, executive compensation, and auditor ratification.

Key Numbers

• 3 — Class III directors (To be elected for a three-year term)
• 2024 — Fiscal Year (Independent auditor appointment for the fiscal year ending December 31, 2024)

Key Players & Entities

• Treace Medical Concepts, Inc. (company) — Registrant
• Grant Thornton LLP (company) — independent registered public accounting firm
• May 21, 2024 (date) — Annual Meeting date
• 2027 (date) — Director term expiration

FAQ

Industry Context

This filing is a standard proxy statement (DEF 14A) used by public companies to solicit votes from shareholders for their annual meetings. It outlines the agenda items and provides information for shareholders to make informed decisions.

Regulatory Implications

The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies.

What Investors Should Do

1. Review the qualifications of the nominated Class III directors.
2. Evaluate the company's executive compensation practices and vote accordingly.
3. Consider the ratification of Grant Thornton LLP as the independent auditor.

Key Dates

• 2024-05-21: Annual Meeting of Stockholders — Virtual meeting for voting on key corporate matters.
• 2024-04-02: Mailing of Proxy Materials — Stockholders will begin receiving notices and access to proxy materials.

Year-Over-Year Comparison

This is the initial filing for the 2024 proxy season, providing details for the upcoming annual meeting.

Filing Documents

• tmci_def_14a_2024_for_fi.htm (DEF 14A) — 904KB
• img3826717_0.jpg (GRAPHIC) — 29KB
• img3826717_1.jpg (GRAPHIC) — 2KB
• img3826717_2.jpg (GRAPHIC) — 22KB
• img3826717_3.jpg (GRAPHIC) — 46KB
• img3826717_4.jpg (GRAPHIC) — 45KB
• img3826717_5.jpg (GRAPHIC) — 22KB
• img3826717_6.jpg (GRAPHIC) — 646KB
• img3826717_7.jpg (GRAPHIC) — 365KB
• 0000950170-24-040228.txt (&nbsp;) — 2526KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 31 SUMMARY COMPENSATION TABLE 31 NARRATIVE TO SUMMARY COMPENSATION TABLE 31 OUTSTANDING EQUITY AWARDS AT 2023 FISCAL YEAR-END 34 PAY VERSUS PERFORMANCE 35 EQUITY COMPENSATION PLANS 38 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 39 STOCK OWNERSHIP 40 STOCKHOLDER PROPOSALS FOR 2025 ANNUAL MEETING OF STOCKHOLDERS 42 DELIVERY OF DOCUMENTS TO STOCKHOLDERS SHARING AN ADDRESS 43 OTHER MATTERS 43 PROXY STATEMENT ANNUAL MEETING OF STOCKHOLDERS May 21, 2024 ABOUT THE MEETING We have sent you this proxy statement and the enclosed proxy card because our board of directors (the Board) is soliciting your proxy for the 2024 Annual Meeting of Stockholders (the Annual Meeting) of Treace Medical Concepts, Inc., a Delaware corporation (the Company, TMCI, we, us or our) and at any adjournment or postponement of the meeting for the purposes described in this proxy statement and the accompanying Notice of 2024 Annual Meeting of Stockholders. &#x2022; This proxy statement summarizes information about the proposals to be considered at the Annual Meeting and other information you may find useful in determining how to vote. &#x2022; The proxy is the means by which you authorize another person to vote your shares in accordance with your instructions. The Annual Meeting will occur on May 21, 2024 at 11:00 a.m., Eastern Time, in a virtual meeting via live webcast on the internet. If you held shares of our common stock as of the close of business on the record date, March 25, 2024 (the Record Date), you are invited to attend the meeting at www.virtualshareholdermeeting.com/TMCI2024 and vote on the proposals described in this proxy statement. There will be no physical meeting location. In addition to solicitations by mail, our directors, officers and regular employees, without additional remuneration, may solicit proxies by telephone, e-mail and personal interviews. We may retain outside consultants to sol